445 related articles for article (PubMed ID: 30388740)
1. Fat Mass and Obesity Associated (
Mizuno TM
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30388740
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression.
Cheng L; Yu P; Li F; Jiang X; Jiao X; Shen Y; Lai X
Hum Cell; 2021 Nov; 34(6):1697-1708. PubMed ID: 34410623
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of hepatic fat mass and obesity associated (Fto) gene expression by insulin.
Mizuno TM; Lew PS; Luo Y; Leckstrom A
Life Sci; 2017 Feb; 170():50-55. PubMed ID: 27914922
[TBL] [Abstract][Full Text] [Related]
4. Fat mass and obesity-associated protein promotes liver steatosis by targeting PPARα.
Wei X; Zhang J; Tang M; Wang X; Fan N; Peng Y
Lipids Health Dis; 2022 Mar; 21(1):29. PubMed ID: 35282837
[TBL] [Abstract][Full Text] [Related]
5. Relationship between blood glucose levels and hepatic Fto mRNA expression in mice.
Poritsanos NJ; Lew PS; Mizuno TM
Biochem Biophys Res Commun; 2010 Oct; 400(4):713-7. PubMed ID: 20816934
[TBL] [Abstract][Full Text] [Related]
6. Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease.
Li S; Wang X; Zhang J; Li J; Liu X; Ma Y; Han C; Zhang L; Zheng L
Braz J Med Biol Res; 2018; 51(8):e7299. PubMed ID: 29924135
[TBL] [Abstract][Full Text] [Related]
7. Betaine increases mitochondrial content and improves hepatic lipid metabolism.
Zhang L; Qi Y; ALuo Z; Liu S; Zhang Z; Zhou L
Food Funct; 2019 Jan; 10(1):216-223. PubMed ID: 30534761
[TBL] [Abstract][Full Text] [Related]
8. FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells.
Chen A; Chen X; Cheng S; Shu L; Yan M; Yao L; Wang B; Huang S; Zhou L; Yang Z; Liu G
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):538-548. PubMed ID: 29486327
[TBL] [Abstract][Full Text] [Related]
9. GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m
Hu Y; Feng Y; Zhang L; Jia Y; Cai D; Qian SB; Du M; Zhao R
RNA Biol; 2020 Jul; 17(7):930-942. PubMed ID: 32116145
[TBL] [Abstract][Full Text] [Related]
10. Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease.
Guo J; Ren W; Li A; Ding Y; Guo W; Su D; Hu C; Xu K; Chen H; Xu X; Yang T; Jia W
Dig Dis Sci; 2013 Apr; 58(4):1004-9. PubMed ID: 23329013
[TBL] [Abstract][Full Text] [Related]
11. In silico profiling of nonsynonymous SNPs of fat mass and obesity-associated gene: possible impacts on the treatment of non-alcoholic fatty liver disease.
Patnaik D; Jena AB; Kerry RG; Duttaroy AK
Lipids Health Dis; 2023 Jan; 22(1):17. PubMed ID: 36717943
[TBL] [Abstract][Full Text] [Related]
12. Methylation and Expression of
Czogała W; Czogała M; Strojny W; Wątor G; Wołkow P; Wójcik M; Bik Multanowski M; Tomasik P; Wędrychowicz A; Kowalczyk W; Miklusiak K; Łazarczyk A; Hałubiec P; Skoczeń S
Nutrients; 2021 May; 13(5):. PubMed ID: 34063412
[TBL] [Abstract][Full Text] [Related]
13. Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.
Tang Z; Sun C; Yan Y; Niu Z; Li Y; Xu X; Zhang J; Wu Y; Li Y; Wang L; Hu C; Li Z; Jiang J; Ying H
J Mol Cell Biol; 2023 Feb; 14(9):. PubMed ID: 36352530
[TBL] [Abstract][Full Text] [Related]
14. The FTO rs9939609 "A" allele is associated with impaired fasting glucose and insulin resistance in Emirati population.
Saber-Ayad M; Manzoor S; El Serafi A; Mahmoud I; Hammoudeh S; Rani A; Abusnana S; Sulaiman N
Gene; 2019 Jan; 681():93-98. PubMed ID: 30273662
[TBL] [Abstract][Full Text] [Related]
15. Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo.
Mittenbühler MJ; Saedler K; Nolte H; Kern L; Zhou J; Qian SB; Meder L; Ullrich RT; Brüning JC; Wunderlich FT
Mol Metab; 2020 Dec; 42():101085. PubMed ID: 32956847
[TBL] [Abstract][Full Text] [Related]
16. Increased recovery rates of phosphocreatine and inorganic phosphate after isometric contraction in oxidative muscle fibers and elevated hepatic insulin resistance in homozygous carriers of the A-allele of FTO rs9939609.
Grunnet LG; Brøns C; Jacobsen S; Nilsson E; Astrup A; Hansen T; Pedersen O; Poulsen P; Quistorff B; Vaag A
J Clin Endocrinol Metab; 2009 Feb; 94(2):596-602. PubMed ID: 18984658
[TBL] [Abstract][Full Text] [Related]
17. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
18. Fat mass and obesity-associated protein regulates lipogenesis via m
Sun D; Zhao T; Zhang Q; Wu M; Zhang Z
Cell Biol Int; 2021 Feb; 45(2):334-344. PubMed ID: 33079435
[TBL] [Abstract][Full Text] [Related]
19. Fat mass and obesity associated gene variants are associated with increased growth hormone levels and affect glucose and lipid metabolism in lean women.
Lukášová P; Vaňková M; Včelák J; Vejražková D; Bradnová O; Stanická S; Hainer V; Bendlová B
Physiol Res; 2015; 64(Suppl 2):S177-85. PubMed ID: 26680478
[TBL] [Abstract][Full Text] [Related]
20. FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.
Kang H; Zhang Z; Yu L; Li Y; Liang M; Zhou L
J Cell Biochem; 2018 Jul; 119(7):5676-5685. PubMed ID: 29384213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
